International Patent: RNA EDITING TO TREAT GENETIC HEARING LOSS ASSOCIATED WITH MUTATIONS IN DFNA5

GENEVA, Aug. 21 -- MASSACHUSETTS EYE AND EAR INFIRMARY filed a patent application (US2026/015306) for “RNA EDITING TO TREAT GENETIC HEARING LOSS ASSOCIATED WITH MUTATIONS IN DFNA5”. With publication no. WO/2026/174223, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....